Skip to Main Content

Paper Details

Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
J Virol
5
2023
ACE2, COVID, MAb WRAIR-2063, N, SARS, SARS-, SARS-CoV-2, Spike Receptor Binding Domain, class V antibodies, epitope, monoclonal, sarbecovirus, sarbecoviruses, severe, severe acute respiratory syndrome, severe acute respiratory syndrome coronavirus 2, spike protein N-terminal domain
Author NameAffiliation
Lingshu WangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Kayvon ModjarradWalter Reed Army Institute of Research
Michael G JoyceWalter Reed Army Institute of Research
Michael G JoyceHenry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Michael G JoyceWalter Reed Army Institute of Research
  • 1 - 5

Datasets

Release 1.2